SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Huaizhong Health Group, Inc. – ‘10-Q’ for 1/31/23 – ‘XML’

On:  Friday, 5/26/23, at 6:06am ET   ·   For:  1/31/23   ·   Accession #:  1640334-23-968   ·   File #:  0-55369

Previous ‘10-Q’:  ‘10-Q’ on 11/4/22 for 7/31/22   ·   Latest ‘10-Q’:  This Filing   ·   1 Reference:  To:  Huaizhong Health Group, Inc. – ‘S-1’ on 12/17/13

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/26/23  Huaizhong Health Group, Inc.      10-Q        1/31/23   27:1M                                     Pubco Reporting … Inc/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    270K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     15K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     11K 
 9: R1          Cover                                               HTML     61K 
10: R2          Balance Sheets                                      HTML     75K 
11: R3          Balance Sheets (Parenthetical)                      HTML     19K 
12: R4          Statements of Operations (Unaudited)                HTML     54K 
13: R5          Statements of Changes in Stockholders Deficit       HTML     30K 
                (Unaudited)                                                      
14: R6          Statements of Cash Flows (Unaudited)                HTML     51K 
15: R7          Summary of Significant Accounting Policies          HTML     15K 
16: R8          Going Concern                                       HTML     14K 
17: R9          Related Party Transactions                          HTML     14K 
18: R10         Subsequent Events                                   HTML     17K 
19: R11         Summary of Significant Accounting Policies          HTML     19K 
                (Policies)                                                       
20: R12         Going Concern (Details Narrative)                   HTML     13K 
21: R13         Related Party Transactions (Details Narrative)      HTML     19K 
22: R14         Subsequent Events (Details Narrative)               HTML     21K 
25: XML         IDEA XML File -- Filing Summary                      XML     40K 
23: XML         XBRL Instance -- huaizhong_10q_htm                   XML    132K 
24: EXCEL       IDEA Workbook of Financial Report Info              XLSX     28K 
 6: EX-101.CAL  XBRL Calculations -- huaizhong-20230131_cal          XML     50K 
 8: EX-101.DEF  XBRL Definitions -- huaizhong-20230131_def           XML     66K 
 5: EX-101.LAB  XBRL Labels -- huaizhong-20230131_lab                XML    217K 
 7: EX-101.PRE  XBRL Presentations -- huaizhong-20230131_pre         XML    158K 
 4: EX-101.SCH  XBRL Schema -- huaizhong-20230131                    XSD     42K 
26: JSON        XBRL Instance as JSON Data -- MetaLinks              101±   140K 
27: ZIP         XBRL Zipped Folder -- 0001640334-23-000968-xbrl      Zip     58K

‘XML’   —   XBRL Instance — huaizhong_10q_htm

This Document is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:huaizhong="http://huaizhong.com/20230131" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="huaizhong-20230131.xsd" xlink:type="simple"/>
<context id="From2022-11-01to2023-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="From2023-03-01to2023-03-27_huaizhong_SannongYouxuanHoldingsLimitedMember_us-gaap_SubsequentEventMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:SannongYouxuanHoldingsLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-01 </startDate>
<endDate> 2023-03-27 </endDate>
</period>
</context>
<context id="AsOf2023-03-27_huaizhong_SannongYouxuanHoldingsLimitedMember_us-gaap_SubsequentEventMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:SannongYouxuanHoldingsLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2023-03-27 </instant>
</period>
</context>
<context id="From2022-11-01to2023-01-31_huaizhong_SoleOfficerAndDirectorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> huaizhong:SoleOfficerAndDirectorMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="From2021-11-01to2022-01-31_huaizhong_soleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:soleOfficerMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-11-01 </startDate>
<endDate> 2022-01-31 </endDate>
</period>
</context>
<context id="From2022-11-01to2023-01-31_huaizhong_soleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:soleOfficerMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="AsOf2022-10-31_us-gaap_LoansPayableMember_huaizhong_SoleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:SoleOfficerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis"> us-gaap:LoansPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-10-31 </instant>
</period>
</context>
<context id="AsOf2023-01-31_us-gaap_LoansPayableMember_huaizhong_SoleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> huaizhong:SoleOfficerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis"> us-gaap:LoansPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2023-01-31 </instant>
</period>
</context>
<context id="AsOf2023-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2023-01-31 </instant>
</period>
</context>
<context id="AsOf2023-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2023-01-31 </instant>
</period>
</context>
<context id="AsOf2023-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2023-01-31 </instant>
</period>
</context>
<context id="From2022-11-01to2023-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="From2022-11-01to2023-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="From2022-11-01to2023-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2023-01-31 </endDate>
</period>
</context>
<context id="AsOf2022-10-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-10-31 </instant>
</period>
</context>
<context id="AsOf2022-10-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-10-31 </instant>
</period>
</context>
<context id="AsOf2022-10-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-10-31 </instant>
</period>
</context>
<context id="AsOf2022-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2022-01-31 </instant>
</period>
</context>
<context id="AsOf2022-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-31 </instant>
</period>
</context>
<context id="AsOf2022-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-31 </instant>
</period>
</context>
<context id="AsOf2022-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-31 </instant>
</period>
</context>
<context id="From2021-11-01to2022-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-11-01 </startDate>
<endDate> 2022-01-31 </endDate>
</period>
</context>
<context id="From2021-11-01to2022-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-11-01 </startDate>
<endDate> 2022-01-31 </endDate>
</period>
</context>
<context id="From2021-11-01to2022-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-11-01 </startDate>
<endDate> 2022-01-31 </endDate>
</period>
</context>
<context id="AsOf2021-10-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2021-10-31 </instant>
</period>
</context>
<context id="AsOf2021-10-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-10-31 </instant>
</period>
</context>
<context id="AsOf2021-10-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-10-31 </instant>
</period>
</context>
<context id="AsOf2021-10-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-10-31 </instant>
</period>
</context>
<context id="From2021-11-01to2022-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<startDate> 2021-11-01 </startDate>
<endDate> 2022-01-31 </endDate>
</period>
</context>
<context id="AsOf2022-10-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2022-10-31 </instant>
</period>
</context>
<context id="AsOf2023-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2023-01-31 </instant>
</period>
</context>
<context id="AsOf2023-05-23">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2023-05-23 </instant>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="Pure">
<measure> pure </measure>
</unit>
<dei:EntityCentralIndexKey contextRef="From2022-11-01to2023-01-31"> 0001593204 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2022-11-01to2023-01-31"> false </dei:AmendmentFlag>
<dei:CurrentFiscalYearEndDate contextRef="From2022-11-01to2023-01-31"> --10-31 </dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalPeriodFocus contextRef="From2022-11-01to2023-01-31"> Q1 </dei:DocumentFiscalPeriodFocus>
<dei:DocumentFiscalYearFocus contextRef="From2022-11-01to2023-01-31"> 2023 </dei:DocumentFiscalYearFocus>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-10-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-10-31" decimals="0" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2022-10-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-01-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-10-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-10-31_us-gaap_LoansPayableMember_huaizhong_SoleOfficerMember" decimals="0" unitRef="USD"> 70922 </us-gaap:DueToRelatedPartiesCurrent>
<dei:DocumentType contextRef="From2022-11-01to2023-01-31"> 10-Q </dei:DocumentType>
<dei:DocumentQuarterlyReport contextRef="From2022-11-01to2023-01-31"> true </dei:DocumentQuarterlyReport>
<dei:DocumentPeriodEndDate contextRef="From2022-11-01to2023-01-31"> 2023-01-31 </dei:DocumentPeriodEndDate>
<dei:DocumentTransitionReport contextRef="From2022-11-01to2023-01-31"> false </dei:DocumentTransitionReport>
<dei:EntityFileNumber contextRef="From2022-11-01to2023-01-31"> 000-55369 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="From2022-11-01to2023-01-31"> HUAIZHONG HEALTH GROUP, INC. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2022-11-01to2023-01-31"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="From2022-11-01to2023-01-31"> 90-1020141 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2022-11-01to2023-01-31"> Tianan Technology Park </dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="From2022-11-01to2023-01-31"> 13/F Headquarters Center Building 16 </dei:EntityAddressAddressLine2>
<dei:EntityAddressAddressLine3 contextRef="From2022-11-01to2023-01-31"> 555 Panyu North Ave, Panyu District </dei:EntityAddressAddressLine3>
<dei:EntityAddressCityOrTown contextRef="From2022-11-01to2023-01-31"> Guangzhou City </dei:EntityAddressCityOrTown>
<dei:EntityAddressCountry contextRef="From2022-11-01to2023-01-31"> CN </dei:EntityAddressCountry>
<dei:CityAreaCode contextRef="From2022-11-01to2023-01-31"> 86 (20) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2022-11-01to2023-01-31"> 2982 9356 </dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="From2022-11-01to2023-01-31"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="From2022-11-01to2023-01-31"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="From2022-11-01to2023-01-31"> Non-accelerated Filer </dei:EntityFilerCategory>
<dei:EntitySmallBusiness contextRef="From2022-11-01to2023-01-31"> true </dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="From2022-11-01to2023-01-31"> true </dei:EntityEmergingGrowthCompany>
<dei:EntityExTransitionPeriod contextRef="From2022-11-01to2023-01-31"> false </dei:EntityExTransitionPeriod>
<dei:EntityShellCompany contextRef="From2022-11-01to2023-01-31"> false </dei:EntityShellCompany>
<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-05-23" decimals="INF" unitRef="Shares"> 31518466 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:Cash contextRef="AsOf2023-01-31" decimals="0" id="fid_2" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2022-10-31" decimals="0" id="fid_3" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-01-31" decimals="0" id="fid_4" unitRef="USD"> 500 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-10-31" decimals="0" id="fid_5" unitRef="USD"> 1250 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2023-01-31" decimals="0" id="fid_6" unitRef="USD"> 500 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2022-10-31" decimals="0" id="fid_7" unitRef="USD"> 1250 </us-gaap:AssetsCurrent>
<us-gaap:Assets contextRef="AsOf2023-01-31" decimals="0" id="fid_8" unitRef="USD"> 500 </us-gaap:Assets>
<us-gaap:Assets contextRef="AsOf2022-10-31" decimals="0" id="fid_9" unitRef="USD"> 1250 </us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="AsOf2023-01-31" decimals="0" id="fid_12" unitRef="USD"> 19600 </us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="AsOf2022-10-31" decimals="0" id="fid_13" unitRef="USD"> 9800 </us-gaap:AccountsPayableCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2023-01-31" decimals="0" id="fid_14" unitRef="USD"> 70922 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-10-31" decimals="0" id="fid_15" unitRef="USD"> 70922 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2023-01-31" decimals="0" id="fid_16" unitRef="USD"> 90522 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2022-10-31" decimals="0" id="fid_17" unitRef="USD"> 80722 </us-gaap:LiabilitiesCurrent>
<us-gaap:Liabilities contextRef="AsOf2023-01-31" decimals="0" id="fid_18" unitRef="USD"> 90522 </us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="AsOf2022-10-31" decimals="0" id="fid_19" unitRef="USD"> 80722 </us-gaap:Liabilities>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-01-31" decimals="0" id="fid_34" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2023-01-31" decimals="INF" id="fid_32" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2023-01-31" decimals="0" id="fid_36" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockValue contextRef="AsOf2023-01-31" decimals="0" id="fid_21" unitRef="USD"> 31518 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="AsOf2022-10-31" decimals="0" id="fid_22" unitRef="USD"> 31518 </us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-01-31" decimals="0" id="fid_23" unitRef="USD"> 257587 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-10-31" decimals="0" id="fid_24" unitRef="USD"> 257587 </us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-01-31" decimals="0" id="fid_25" unitRef="USD"> -379127 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-10-31" decimals="0" id="fid_26" unitRef="USD"> -368577 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="AsOf2023-01-31" decimals="0" id="fid_27" unitRef="USD"> -90022 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-10-31" decimals="0" id="fid_28" unitRef="USD"> -79472 </us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-01-31" decimals="0" id="fid_29" unitRef="USD"> 500 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-10-31" decimals="0" id="fid_30" unitRef="USD"> 1250 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:Revenues contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_39" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_40" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:ProfessionalFees contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_42" unitRef="USD"> 9800 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_43" unitRef="USD"> 9725 </us-gaap:ProfessionalFees>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_44" unitRef="USD"> 750 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_45" unitRef="USD"> 0 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_46" unitRef="USD"> 10550 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_47" unitRef="USD"> 9725 </us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_48" unitRef="USD"> -10550 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_49" unitRef="USD"> -9725 </us-gaap:OperatingIncomeLoss>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_50" unitRef="USD"> -10550 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_51" unitRef="USD"> -9725 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_52" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_53" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_54" unitRef="USD"> -10550 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_55" unitRef="USD"> -9725 </us-gaap:NetIncomeLoss>
<huaizhong:NetLossPerCommonShareBasicAndDiluted contextRef="From2022-11-01to2023-01-31" decimals="INF" id="fid_56" unitRef="USDPShares"> -0.0003 </huaizhong:NetLossPerCommonShareBasicAndDiluted>
<huaizhong:NetLossPerCommonShareBasicAndDiluted contextRef="From2021-11-01to2022-01-31" decimals="INF" id="fid_57" unitRef="USDPShares"> -0.0003 </huaizhong:NetLossPerCommonShareBasicAndDiluted>
<huaizhong:BasicAndDilutedWeightedAverageCommonSharesOutstanding contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_58" unitRef="Shares"> 31518466 </huaizhong:BasicAndDilutedWeightedAverageCommonSharesOutstanding>
<huaizhong:BasicAndDilutedWeightedAverageCommonSharesOutstanding contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_59" unitRef="Shares"> 31518466 </huaizhong:BasicAndDilutedWeightedAverageCommonSharesOutstanding>
<us-gaap:SharesIssued contextRef="AsOf2022-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_84" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2022-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_61" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-10-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_62" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-10-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_63" unitRef="USD"> -368577 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-10-31" decimals="0" id="fid_64" unitRef="USD"> -79472 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_65" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_66" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_67" unitRef="USD"> -10550 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_68" unitRef="USD"> -10550 </us-gaap:NetIncomeLoss>
<us-gaap:SharesIssued contextRef="AsOf2023-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_69" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2023-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_70" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2023-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_71" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2023-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_72" unitRef="USD"> -379127 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2023-01-31" decimals="0" id="fid_73" unitRef="USD"> -90022 </us-gaap:StockholdersEquity>
<us-gaap:SharesIssued contextRef="AsOf2022-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_74" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_76" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-10-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_77" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-10-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_78" unitRef="USD"> -339406 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-10-31" decimals="0" id="fid_79" unitRef="USD"> -50301 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_80" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_81" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_82" unitRef="USD"> -9725 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_83" unitRef="USD"> -9725 </us-gaap:NetIncomeLoss>
<us-gaap:SharesIssued contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_75" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2022-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_85" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_86" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_87" unitRef="USD"> -349131 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-01-31" decimals="0" id="fid_88" unitRef="USD"> -60026 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_90" unitRef="USD"> -10550 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_91" unitRef="USD"> -9725 </us-gaap:NetIncomeLoss>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_93" unitRef="USD"> 0 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_136" unitRef="USD"> 0 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_138" unitRef="USD"> 750 </us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_96" unitRef="USD"> 0 </us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_97" unitRef="USD"> 9800 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_98" unitRef="USD"> 50 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_99" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_100" unitRef="USD"> -9675 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<huaizhong:ProceedsFromRelatedPartyAdvancesFundingOperations contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_102" unitRef="USD"> 0 </huaizhong:ProceedsFromRelatedPartyAdvancesFundingOperations>
<huaizhong:ProceedsFromRelatedPartyAdvancesFundingOperations contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_103" unitRef="USD"> 9675 </huaizhong:ProceedsFromRelatedPartyAdvancesFundingOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_104" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_105" unitRef="USD"> 9675 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_106" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_107" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-10-31" decimals="0" id="fid_108" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-10-31" decimals="0" id="fid_109" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-01-31" decimals="0" id="fid_110" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-01-31" decimals="0" id="fid_111" unitRef="USD"> 0 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:IncomeTaxesPaidNet contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_113" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_114" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:InterestPaidNet contextRef="From2022-11-01to2023-01-31" decimals="0" id="fid_115" unitRef="USD"> 0 </us-gaap:InterestPaidNet>
<us-gaap:InterestPaidNet contextRef="From2021-11-01to2022-01-31" decimals="0" id="fid_116" unitRef="USD"> 0 </us-gaap:InterestPaidNet>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-11-01to2023-01-31" id="fid_117">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Basis of Presentation of Unaudited Interim Financial Statements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2022, as filed with the SEC on March 27, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Use of Estimates</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Reclassification</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-11-01to2023-01-31" id="fid_121">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2022, as filed with the SEC on March 27, 2023.</p>
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="From2022-11-01to2023-01-31" id="fid_122">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p>
</us-gaap:UseOfEstimates>
<huaizhong:ReclassificationPolicyTextblock contextRef="From2022-11-01to2023-01-31" id="fid_123">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p>
</huaizhong:ReclassificationPolicyTextblock>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-11-01to2023-01-31" id="fid_118">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 2 - GOING CONCERN</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of January 31,2023, the Company has suffered recurring losses from operations, has an accumulated deficit of $379,127 and has not earned any revenues. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p>
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-01-31" decimals="0" id="fid_124" unitRef="USD"> -379127 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-11-01to2023-01-31" id="fid_119">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 3 - RELATED PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the three months ended January 31,2023 and 2022, the Company’s sole officer advanced to the Company an amount of $0 and $9,675 by paying for expenses on behalf of the Company. As of January 31, 2023, and October 31, 2022, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $70,922, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Other</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the CEO and President, of the Company to use at no charge.</p>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<huaizhong:IncreaseDecreaseInRelatedPartyAdvancesFundingOperations contextRef="From2022-11-01to2023-01-31_huaizhong_soleOfficerMember" decimals="0" id="fid_129" unitRef="USD"> 0 </huaizhong:IncreaseDecreaseInRelatedPartyAdvancesFundingOperations>
<huaizhong:IncreaseDecreaseInRelatedPartyAdvancesFundingOperations contextRef="From2021-11-01to2022-01-31_huaizhong_soleOfficerMember" decimals="0" id="fid_130" unitRef="USD"> 9675 </huaizhong:IncreaseDecreaseInRelatedPartyAdvancesFundingOperations>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2023-01-31_us-gaap_LoansPayableMember_huaizhong_SoleOfficerMember" decimals="0" id="fid_127" unitRef="USD"> 70922 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:SubsequentEventsTextBlock contextRef="From2022-11-01to2023-01-31" id="fid_120">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 4 - SUBSEQUENT EVENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated subsequent events from January 31, 2023, through the date these financial statements were issued and determined no additional events to disclose, except as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s sole officer and director advanced to the Company an amount of $18,000 by paying operating expenses on behalf of the Company.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 27, 2023, the Company entered into a Share Exchange Agreement (the “<strong>Share Exchange Agreement</strong><strong>”</strong>) with Sannong Youxuan (BVI) Limited (“<strong>Target</strong><strong>”),</strong> and Sannong Youxuan Holdings Limited, the sole shareholder of the Target (the “<strong>Seller</strong>”), pursuant to which, among other things and subject to the terms and conditions contained therein, the Company agreed to effect an acquisition of the Target by acquiring from the Seller 100% of the ordinary shares issued and outstanding of the Target. The target is engaged in the business of software development, block chain technology and mobile application development.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the Share Exchange Agreement, in exchange for the acquisition of 100% of the ordinary shares   issued and outstanding of the Target, the Company issued an aggregate of 1,000,000 shares of common stock, par value $0.001 per share, of the Company to the Seller. At the closing of the acquisition, the Company entered into a lock-up agreement with the Seller with respect to the exchange shares, pursuant to which the Sellers agreed, subject to certain exceptions, not to transfer the exchange shares, or publicly disclose the intention to do so, from the closing of the acquisition until the six months anniversary of the closing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Share Exchange Agreement contains customary representations and warranties made by the Company, on the one hand, and the Target and the Seller on the other hand, made solely for the benefit of the other, which in certain cases are subject to specified exceptions and qualifications contained in the Share Exchange Agreement or in information provided pursuant to certain disclosure schedules to the Share Exchange Agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At the date of filing this Financial Statements, the acquisition was not completed and the shares has not been issued. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prior to the acquisition of the Target on March 27, 2023, the Company was considered a shell company. Effective on March 27, 2023, upon the closing of the acquisition of the Target, the Company has changed its status as a shell company and is no longer deemed to be a shell company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The operations of the Target were fully integrated into the Company since March 27, 2023. Target was formed in 2016 and has been active in the business of supplemental nutrition products distribution. Since Target’s acquisition by the Company, Target has continued to its operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">As a result of the continuing operations of the Target as a wholly owned subsidiary of the Company, the Company has become an operating entity and, thus, not an entity with “no or nominal operations”. Therefore, the Company no longer meets the SEC definition of a Shell Company.</p>
</us-gaap:SubsequentEventsTextBlock>
<us-gaap:PaymentsForOperatingActivities contextRef="From2022-11-01to2023-01-31_huaizhong_SoleOfficerAndDirectorMember" decimals="0" id="fid_131" unitRef="USD"> 18000 </us-gaap:PaymentsForOperatingActivities>
<huaizhong:AcquisitionOfOrdinarySharesIssuedAndOutstanding contextRef="From2023-03-01to2023-03-27_huaizhong_SannongYouxuanHoldingsLimitedMember_us-gaap_SubsequentEventMember" decimals="INF" id="fid_137" unitRef="Pure"> 1 </huaizhong:AcquisitionOfOrdinarySharesIssuedAndOutstanding>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2023-03-27_huaizhong_SannongYouxuanHoldingsLimitedMember_us-gaap_SubsequentEventMember" decimals="0" id="fid_135" unitRef="Shares"> 1000000 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2023-03-27_huaizhong_SannongYouxuanHoldingsLimitedMember_us-gaap_SubsequentEventMember" decimals="INF" id="fid_133" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
</xbrl>

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/17/13  Huaizhong Health Group, Inc.      S-1                    7:4.5M                                   Discount Edgar/FA
↑Top
Filing Submission 0001640334-23-000968   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 1:20:32.1pm ET